The 40,000-ft.2 facility will feature eight cleanrooms with configurations for the production of cell and viral vector products.
Fujifilm and The Massachusetts Center for Advanced Biological Innovation and Manufacturing announced on Jan. 14, 2021 that they are investing $76 million into a new manufacturing and innovation center in Watertown, MA.
The 40,000-ft.2 facility will feature eight cleanrooms with configurations for the production of cell and viral vector products, Fujifilm said in a company press release. The site will all also provide quality control, lab, office, and convening space for academia, industries, and hospitals.
Operations at the center will begin in early 2022.
“Fujifilm is pleased to partner with leading academia, industry, and teaching hospitals, to explore the application of genetically modified cell therapies, and bring new treatment options to the market,” said Takatoshi Ishikawa, senior executive vice-president and chief life science officer, Fujifilm, in the press release. “This collaboration supports our larger healthcare strategy to utilize the combined strength of the Fujifilm Group’s products and services to offer personalized life-altering treatment options to clinicians and their patients.”
Source:
